Finance
Most Popular
More Posts on Finance
New Strong Buy Stocks for January 26th
FLGT, LPX, STC, GFED, and FBNC have been added to the Zacks Rank #1 (Strong Buy) List on January 26th.
Freeport's (FCX) Earnings and Revenues Lag Estimates in Q4
Freeport's (FCX) Q4 copper sales were driven by the ramp-up of underground mining at PT-FI and higher milling rates across North America and South America.
Lincoln National (LNC) Launches Enhanced Version of AssetEdge
Lincoln National (LNC) unveils AssetEdge VUL (2022) for offering bundled benefits of added income, varied investment options and death benefit protection.
Best Growth Stocks to Buy for January 26th
CWK, SIG, and M made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 26, 2022.
4 Retailers Scoring Decent Sales Numbers in the Holiday Season
Retailers enhance customer engagement and make logistics improvements to make the most of the festive season. Five Below (FIVE), Zumiez (ZUMZ), Signet (SIG) and Tilly's (TLYS) score decent holiday sales.
Amphenol (APH) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
Amphenol's (APH) Q4 results reflect robust growth in the IT data communications, industrial, mobile networks, commercial air, automotive and broadband end-markets.
Endeavour Silver (EXK) Provides '22 Production & Cost View
Endeavor Silver (EXK) expects silver equivalent production between 6.7 million and 7.6 million ounces in 2022, lower than 2021 due to lower ore grades at Guanacevi.
DaVita's (DVA) Collaboration to Aid in Kidney Care Needs
DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.
Stock Market “Nausea Index” Going Off
The stock market (SPY) has seen fresh lows this week scaring many investors into selling their positions. On the other hand, 40 year investment veteran shares a proprietary market indicator...
Fed News to Prompt Stock Markets Today
This would be an excellent time for Fed Chair Powell to address investors' worry.
Abbott's (ABT) Q4 Earnings and Revenues Beat Estimates
Abbott's (ABT) COVID-19 testing-related sales in Q4 increased on demand for BinaxNOW, Panbio and ID NOW rapid testing platforms.
General Dynamics' (GD) Q4 Earnings Beat Estimates, Sales Lag
General Dynamics' (GD) fourth-quarter earnings are better than expected. The company continues to secure orders for different business segments.